about
Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional studyThe role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseasesPancreatic regulation of glucose homeostasisFibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan CrosstalkFibroblast Growth Factor Signaling in Metabolic RegulationResearch Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLDFGF21 and Cardiac PhysiopathologyInventing new medicines: The FGF21 storyRunning forward: new frontiers in endurance exercise biologyStressed Liver and Muscle Call on Adipocytes with FGF21FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic DiseasesBile acid sequestration reduces plasma glucose levels in db/db mice by increasing its metabolic clearance rateMetabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and HepatokinesInflammation induced loss of skeletal muscleMuscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injuryA better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycolMyonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasisAmpelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling PathwayModulating fibroblast growth factor 21 in hyperphagic OLETF rats with daily exercise and caloric restrictionGlucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytesMeteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesisExercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.Serum FGF21 levels are associated with brown adipose tissue activity in humans.Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and DiseasesFibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR).Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hormones of energy balance in a TCDD-sensitive and a TCDD-resistant rat strain.Insulin-like 6 is induced by muscle injury and functions as a regenerative factor.Diminished mTOR signaling: a common mode of action for endocrine longevity factors.Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIVActivation of Liver FGF21 in hepatocarcinogenesis and during hepatic stressFibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.Acute exercise induces FGF21 expression in mice and in healthy humansBimodal effect on pancreatic β-cells of secretory products from normal or insulin-resistant human skeletal muscleThermogenic activation induces FGF21 expression and release in brown adipose tissue.Metabolomic analysis of akt1-mediated muscle hypertrophy in models of diet-induced obesity and age-related fat accumulation.Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females.Glucagon stimulates hepatic FGF21 secretion through a PKA- and EPAC-dependent posttranscriptional mechanism.
P2860
Q21135215-F3559F37-C765-4ECE-BD23-B77A13FE0BCEQ21296864-569DFD4C-EDE6-4555-BA96-83FFE03849D9Q26766485-A4B2B871-4EB6-4BB2-9F3D-C679578D9F7CQ26766528-55742AEF-9D63-4492-9C6D-E50E72837FE4Q26772751-0F392CD1-09A1-4975-8331-9155400BF19DQ26781431-4E286741-3084-4423-8054-23460B2E990DQ26784524-03E07ED3-82CE-450F-B997-6EFFFBE1A55DQ26823319-D2CF4D3D-39E6-48BA-9867-B8CC32C8BFC6Q26824141-36978C03-AA54-4DDB-BC53-51E5B380F412Q27014973-276C15DE-E8EE-4D98-BB2B-1204446839BDQ27028013-A6F02FDC-E46A-4BFD-94DD-61F1388FD0A4Q27321021-E64C3C14-7A82-4705-B5AE-A23B735EE5CDQ28066564-CC760BDD-59A0-4099-8AF0-F35A335F137EQ28083759-1661101E-65F0-40B0-A866-7472565C098AQ28238431-7A383D5A-BCB0-4BB2-9979-4D7E2B5A680AQ28478454-158157B7-F591-49DD-A385-68B84EB2B7D7Q28511505-DE0439D4-083F-4602-B0E2-3504CE317377Q28552475-74722351-B60E-4582-8AA4-2177F6A506E1Q28570349-87DC72B1-A8C8-4135-9D4F-2D740DD19422Q28571616-E5B6D61D-4A49-415B-BD33-A09E2D764145Q28594803-942FF1D6-7400-434A-88EA-AB151FB518A2Q30238666-C3498F11-E265-4EE6-8C09-454BBD93F5FEQ30374773-C9909134-1556-48CC-ACD1-517CFC1CDFFAQ33751398-D2388E64-8A03-4C5C-B241-DFF69AB48DA9Q33779662-10AD36D9-F71F-421D-B7F7-76F1076B1EB6Q33851027-1941BF99-A98C-4607-8098-2BD010120F95Q33875481-047D5D88-2C3D-4C1B-AB01-CF1E4BA3EAEDQ34031701-22AD900B-E35A-42D6-9112-75C0D5EA9CCAQ34158496-8CB5871D-0A1D-487E-A282-0C490FA2F369Q34285424-E8CA4709-6D3A-49EC-AECC-BA358BA77DC0Q34462362-BB6FA387-FDCF-4797-B09F-DE9126B9A21FQ34637577-AAA069FA-119A-4AC2-A48A-356BEA4F4AB2Q34670357-2F74E208-26AB-4EE1-BE23-76BB3CD73F5BQ34674492-7EC8CA9B-9B25-4FBA-858E-EA07F62FC9C6Q34718217-E988C843-93E5-49DD-9BDB-4CC1A22D0FC6Q34718673-F80541DC-17FF-4319-A8CE-2FD62E244BDCQ34787051-9A5E9484-6D30-4E61-B6EF-67EEDF30DEFEQ34855354-5047FABA-9D88-4810-8ECE-1747E53756D7Q34899333-AB189C0F-6052-4366-B15E-ED72684B6C15Q35147964-A03F079F-1E23-41FB-A2C0-777818B56FD4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FGF21 is an Akt-regulated myokine.
@en
FGF21 is an Akt-regulated myokine.
@nl
type
label
FGF21 is an Akt-regulated myokine.
@en
FGF21 is an Akt-regulated myokine.
@nl
prefLabel
FGF21 is an Akt-regulated myokine.
@en
FGF21 is an Akt-regulated myokine.
@nl
P2093
P2860
P1433
P1476
FGF21 is an Akt-regulated myokine.
@en
P2093
Alexei Kharitonenkov
Holly A Bina
Kenneth Walsh
Noriyuki Ouchi
Yasuhiro Izumiya
Yuichi Akasaki
P2860
P304
P356
10.1016/J.FEBSLET.2008.10.021
P407
P577
2008-10-21T00:00:00Z